LATEST NEWS
- 11:50 AM OBC a market performer, target of Rs 278: Karvy
- 11:50 AM RIL readying $25bn for global shopping: Source...
- 11:40 AM Dickens Christmas classic tops UK box office
- 11:39 AM Use upside to book profits in Educomp: Gujral
- 11:37 AM Stay invested in Educomp Solution: Mukadam
- 11:35 AM Sensex up over 150 pts; IT, metals, cap goods, pha...
- 11:32 AM Govt's GST draft positive for India: Experts
- 11:29 AM Reliance prospecting for diamonds
- 11:28 AM Neyveli Lignite has target of Rs 180-185: Gujral
- 11:25 AM NMDC, AP body to enter mining pact



Buy Lupin; target of Rs 670: Sharekhan
Published on Thu, Dec 21, 2006 at 10:39 | Updated at Thu, Dec 21, 2006 at 10:41 | Source : Moneycontrol.com
Broking house, Sharekhan keeps buy rating on Lupin with price target of Rs 670.
Sharekhan report on Lupin:
Key points
- Lupin has obtained a tentative approval from the US Food and Drug Authority (USFDA) for its abbreviated new drug application for Trandolapril tablets of strengths 1mg, 2mg and 4mg. Trandolapril is prescribed for the treatment of hypertension.
- Abbot Laboratories Plc, USA is the innovator of Trandolapril, which is sold under the brand name MavikÆ. The annual sales of the product in the USA stood at approximately USD 53 million for the twelve months ended July 2006, based on IMS data. The product patent expires in June 2007.
- Lupin would launch the generic equivalent of the MavikÆ tablets in US markets on receiving the final approval from the USFDA. The final permission is expected upon the expiry of the patent protection for the branded product in June 2007.
- Anticipating a 25% market share for Lupin at a 30% price erosion, we expect the product to generate revenues worth Rs27.8 crore (for the eight months after the expiry of the patent in June 2007) in FY2008.
- At the current market price of Rs 582, Lupin is quoting at 14.9x its FY2008E earnings estimate, on a fully diluted basis. Keeping in mind the strong business fundamentals and growth potential of the company, we maintain our Buy recommendation on the stock with a price target of Rs 670.
|
Stock Advice
|
|
|
WE ARE 10 !


Today's Special Column
with Pronab Sen
Union Ministry of Statistics and Programme Implementation , Chief Statistician and Secretary


WHAT OTHERS LIKE
-
Most Read
-
Most Viewed
24 Hours
7 Days
1 Month
- 10 companies that MF managers love
- 10 Companies that FIIs love
- Experts on stocks and sectors to pick/avoid now

- Ganeshaspeaks: Market prediction for Nov 11
- IPO scam: SEBI bars Pyramid Saimira for 7 years

- Mitesh Thacker's top picks for today's trade

- Sensex may drift down to 12500, -ve on RIL: Shankar Sharma

- How greed got the better of this Morgan Stanley star
- Stay invested in Educomp Solution: Mukadam
Source: CNBC-TV18
- Sensex up over 150 pts; IT, metals, cap goods, pharma gain
Source: Moneycontrol.com
- Neyveli Lignite has target of Rs 180-185: Gujral
Source: CNBC-TV18
- NMDC, AP body to enter mining pact
Source: Business Line
NEWS FROM OUR PARTNERS
- NMDC, AP body to enter mining pact
Source: Business Line
- Volvo-Eicher semi low-floor buses to hit the roads next yr
Source: Business Line
- Petronet likely to award LNG jetty contract next month
Source: Business Line
- NTPC units shut down on coal shortage
Source: Business Line
©Network 18, 2009. All Rights Reserved





















